UNION CITY, Calif.,
April 21, 2015 /PRNewswire/
-- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care instruments and consumables for the
medical, research, and veterinary markets worldwide, has scheduled
a conference call to discuss its financial results for the fourth
quarter and fiscal year 2015, ended March
31, 2015. The call will be at 4:15
p.m. ET on Thursday, April 30,
2015. The Company will report financial results for the
fourth quarter and fiscal year 2015 after the market closes on
Thursday, April 30, 2015.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
Company's website at www.abaxis.com. A replay of the call is
available by visiting www.abaxis.com for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code
10064238, through May 6, 2015.
About Abaxis
Abaxis develops, manufactures, markets and sells portable blood
analysis systems for use in any veterinary or human patient-care
setting to provide clinicians with rapid blood constituent
measurements. The system consists of a compact, 5.1 kilogram (11.2
pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs, which contain all the chemicals
required to perform a panel of up to 13 tests on veterinary
patients and 14 tests on human patients. The system can be
operated with minimal training and performs multiple routine tests
on whole blood, serum or plasma samples. The system provides test
results in less than 12 minutes with the precision and accuracy
equivalent to a clinical laboratory analyzer. The veterinary
business also provides to the animal health and research market a
line of hematology instruments for point-of-care complete blood
counts (CBC), a specialty instrument to screen for and detect
clotting disorders and to measure equine fibrinogen levels, a
handheld instrument for the rapid assessment of certain critical
care tests and rapid point-of-care tests for Heartworm infections,
Parvovirus, Giardia, Lyme disease, Ehrlichia, Anaplasma, and
FeLV-FIV. For more information, visit http://www.abaxis.com.
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive Officer
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
Abaxis,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abaxis-to-report-fourth-quarter-and-fiscal-year-2015-financial-results-thursday-april-30-2015-300069183.html
SOURCE Abaxis, Inc.